This question tests appropriate PPE selection when manipulating oral hazardous drugs that may generate dust or particles. Methotrexate is an antimetabolite chemotherapy agent classified as hazardous, requiring protection even at low rheumatologic doses due to its cytotoxic and teratogenic properties. The correct answer (A) specifies chemotherapy-tested gloves for all handling and adds a gown when splitting or crushing tablets, as these activities generate dust that can be inhaled or settle on skin and clothing. Option B incorrectly suggests dose frequency or tablet size affects hazard classification. Option C provides inadequate protection as masks alone don't prevent skin exposure, which is the primary route for tablet handling. Option D incorrectly limits protection to sterile gloves (unnecessary for this purpose) and restricts gown use to IV preparations only. Remember that any manipulation of hazardous drug tablets (splitting, crushing, or cleaning up broken tablets) increases exposure risk and requires additional PPE beyond gloves, and facilities should have dedicated equipment and areas for these activities when possible.

This question tests recognition of significant drug interactions that can lead to serious adverse events in vulnerable populations. Trimethoprim/sulfamethoxazole (TMP/SMX) is a potent inhibitor of CYP2C9, the primary enzyme responsible for warfarin metabolism, leading to decreased warfarin clearance and significantly increased INR with heightened bleeding risk. The correct answer (A) identifies this clinically significant interaction requiring either selection of an alternative antibiotic or intensive INR monitoring with likely warfarin dose reduction during and after TMP/SMX therapy. Option B is incorrect because TMP/SMX tablets are stored at room temperature. Option C incorrectly applies a tetracycline/quinolone interaction to TMP/SMX, which doesn't chelate with calcium. Option D is wrong because while TMP/SMX can rarely cause QT prolongation, this isn't the primary concern and doesn't require routine ECG monitoring in all patients. When managing this interaction, check baseline INR, consider empiric warfarin dose reduction of 25-50%, monitor INR within 3-5 days, and continue monitoring for at least a week after completing antibiotics due to the prolonged effect on warfarin metabolism.

This question tests recognition of critical safety measures to prevent fatal medication errors with high-alert hazardous drugs. Intrathecal methotrexate administration errors, particularly accidental IV administration of intrathecal doses or vice versa, have resulted in patient deaths due to the vastly different dosing ranges and the catastrophic effects of overdose via the intrathecal route. The correct answer (B) implements essential safety barriers including distinct labeling with route-specific warnings, physical segregation from IV chemotherapy, and use of specialized syringes that cannot connect to IV lines. Option A addresses storage but misses the critical wrong-route risk. Option C is extremely dangerous as storing intrathecal and IV preparations together increases confusion risk. Option D incorrectly minimizes hazardous drug precautions and fails to address the wrong-route risk. Best practices include using intrathecal-specific syringes, requiring independent double-checks, implementing forcing functions in electronic systems, and considering preparation in a separate location or time from IV chemotherapy to create physical and temporal barriers against fatal errors.

This question tests knowledge of appropriate PPE when handling oral hazardous drugs, particularly those with reproductive risks. Both bicalutamide and finasteride are antiandrogenic agents classified as hazardous drugs due to their potential for reproductive toxicity, making protection especially critical for pregnant healthcare workers. The correct answer (B) specifies wearing chemotherapy-tested gloves (which meet ASTM D6978 standards for chemotherapy drug permeation) when handling intact tablets and emphasizes avoiding crushing or splitting to prevent aerosolization, followed by proper hand hygiene. Option A is incorrect because oral hazardous drugs still pose exposure risks through skin contact and potential dust generation. Option C is inadequate because masks alone don't prevent skin exposure, which is the primary route for intact tablets. Option D incorrectly specifies sterile gloves (unnecessary for medication administration) and dismisses gown use, though gowns may be needed if crushing is required. Remember that pregnant healthcare workers should minimize exposure to all hazardous drugs, and facilities should have policies allowing reassignment when handling drugs with reproductive toxicity.

This question tests the pharmacy safety concept of personal protective equipment (PPE) requirements for handling hazardous drugs during administration outside the compounding area. Docetaxel is a hazardous antineoplastic agent that requires specific PPE to minimize occupational exposure risks such as skin contact or inhalation. Choice B ensures safe and compliant practice by mandating chemotherapy-tested gloves and a gown, with additional protection for splash risks, aligning with USP <800> guidelines for administration. Choice A is incorrect because even non-compounding administration of hazardous drugs requires full PPE to prevent exposure, not just gloves. Choice C is suboptimal as a surgical mask alone does not address dermal exposure, and gloves are essential; choice D is wrong because sterile PPE is not sufficient without chemotherapy testing for hazardous drugs. Always assess the route and activity for appropriate PPE levels when handling hazardous drugs. A useful framework is to follow the NIOSH hazardous drug list and USP <800> for consistent safety protocols across settings.

This question tests understanding of proper storage requirements for reconstituted antibiotic suspensions to maintain stability and prevent therapeutic failure. Amoxicillin/clavulanate oral suspension contains clavulanic acid, which is particularly unstable at room temperature and degrades rapidly, leading to reduced efficacy against beta-lactamase producing bacteria. The correct answer (C) ensures medication stability by requiring refrigeration (2-8°C) after reconstitution with a 10-day expiration date, which maintains the potency of both active ingredients throughout the treatment course. Option A is incorrect because room temperature storage causes rapid degradation of clavulanic acid within days. Option B is incorrect because freezing can cause physical separation of suspension components and alter drug distribution. Option D is dangerously wrong because direct sunlight accelerates degradation and the 14-day expiration exceeds stability limits. Always counsel caregivers to shake suspensions well before each dose, use the provided measuring device, and mark the discard date on the bottle to prevent administration of degraded medication.

This question tests proper disposal procedures for hazardous medications to prevent environmental contamination and accidental exposure. Isotretinoin is classified as a hazardous drug due to its severe teratogenic effects, requiring special disposal procedures that prevent exposure to pregnant women and environmental contamination. The correct answer (C) ensures safe disposal through pharmacy take-back programs or designated hazardous medication collection systems, with proper handling using gloves and maintaining original container labeling when possible. Option A is incorrect because flushing isotretinoin contaminates water systems and poses environmental risks. Option B is dangerous because opening capsules creates exposure risk and household trash disposal allows potential contact by others, including pregnant women. Option D is incorrect because sharps containers are for needles and syringes, not oral medications, and isotretinoin requires hazardous waste disposal, not biohazard disposal. Always educate patients that hazardous drugs should never enter household trash or water systems, and provide information about local take-back programs or DEA-authorized collection sites for safe disposal.

This question tests system-level safety strategies for preventing fatal errors with concentrated electrolytes. Concentrated potassium chloride is a high-alert medication because inadvertent IV push administration causes immediate cardiac arrest, with numerous deaths reported from confusion between diluted and concentrated preparations. The correct answer (B) implements crucial safety barriers by preferentially using premixed, appropriately diluted KCl infusions and removing concentrated vials from floor stock, requiring pharmacy preparation and verification for any concentrated electrolyte dilution. Option A is extremely dangerous as it increases accessibility for potential fatal errors. Option C addresses storage temperature but misses the critical administration safety issue. Option D describes a lethal practice - concentrated KCl must never be given IV push as it causes immediate asystole. Effective system safeguards include removing concentrated electrolytes from patient care areas, using premixed solutions, requiring pharmacy dilution, implementing barcode scanning, and using smart pump libraries with hard limits to prevent concentrated electrolyte administration errors.

This question tests knowledge of insulin storage requirements to maintain potency and prevent medication errors during travel. Insulin is a protein hormone that denatures when exposed to temperature extremes, losing its glucose-lowering efficacy and potentially leading to hyperglycemic emergencies. The correct answer (A) follows manufacturer guidelines: unopened pens require refrigeration (2-8°C) to maintain potency until expiration date, while in-use pens can be kept at room temperature (below 86°F/30°C) for a specified period (typically 28 days for most insulins) to improve injection comfort, but must be protected from heat and direct sunlight. Option B incorrectly reverses storage requirements and extends in-use dating beyond safe limits. Option C is wrong because freezing permanently damages insulin's protein structure. Option D is dangerous as sunlight and heat rapidly degrade insulin. For travel, advise patients to carry insulin in insulated cases without direct ice contact, never leave it in hot cars, and bring extra supplies with proper documentation for air travel, ensuring continuous access to this life-sustaining medication.

This question tests the pharmacy safety concept of handling intact oral hazardous drugs to minimize exposure. Lenalidomide is hazardous and teratogenic, requiring gloves and no manipulation to avoid residue. Choice B ensures safe and compliant practice by maintaining integrity and cleaning per procedures, per USP <800>. Choice A is incorrect as opening increases exposure; choice C is suboptimal because refrigeration is not required. Choice D is wrong as blowing powder spreads contamination. Restrict handling by pregnant staff. A framework is to use unit-of-use packaging for hazardous orals when possible.